125 related articles for article (PubMed ID: 2349630)
1. Transfusion of red cells after autologous bone marrow harvest in patients with acute leukemia and malignant lymphoma.
Sonneveld P; de Leeuw CA; Schipperus M; Lindemans J; Abels J
Transfusion; 1990 May; 30(4):310-3. PubMed ID: 2349630
[TBL] [Abstract][Full Text] [Related]
2. Transfusion of bone marrow red cells during bone marrow harvests.
Rosenfeld CS; Tedrow HE; Bryan R; Mangan KF; Shadduck RK
Exp Hematol; 1988 Sep; 16(8):702-4. PubMed ID: 3042443
[TBL] [Abstract][Full Text] [Related]
3. Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cells.
Ciobanu N; Weinberg V; Sparano JA; Zervos G; Walewski J; Spivack M; Wiernik PH
Transfusion; 1992; 32(3):231-4. PubMed ID: 1557804
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
5. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
6. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Vellenga E; van Agthoven M; Croockewit AJ; Verdonck LF; Wijermans PJ; van Oers MH; Volkers CP; van Imhoff GW; Kingma T; Uyl-de Groot CA; Fibbe WE
Br J Haematol; 2001 Aug; 114(2):319-26. PubMed ID: 11529850
[TBL] [Abstract][Full Text] [Related]
7. Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.
Jerjis S; Croockewit S; Muus P; Schaap N; Preijers F; de Witte T
Leuk Lymphoma; 1999 Dec; 36(1-2):33-43. PubMed ID: 10613448
[TBL] [Abstract][Full Text] [Related]
8. [Transplantation of autologous bone marrow--a new approach in the treatment of neoplastic hematologic diseases. II. Clinical results in acute leukemia, malignant lymphoma and solid tumors].
Nemet D
Lijec Vjesn; 1990; 112(1-2):53-8. PubMed ID: 2366622
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991
[TBL] [Abstract][Full Text] [Related]
11. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
Sallerfors B; Olofsson T; Lenhoff S
Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow].
Nemet D; Labar B; Bogdanić V; Kolevska T; Mrsić M; Pavletić Z; Kalenić S; Vrtar M; Marusić M; Markulin-Grgić L
Lijec Vjesn; 1989; 111(9-10):348-53. PubMed ID: 2633014
[TBL] [Abstract][Full Text] [Related]
14. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M
N Engl J Med; 1991 Jun; 324(25):1773-8. PubMed ID: 1903847
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
17. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Damon LE; Rugo HS; Ries CA; Linker CA
Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of engraftment after repeated autologous bone marrow transplantation.
van Besien K; Nichols CR; Tricot G; Langefeld C; Miller ME; Akard L; English DK; Graves VL; Cheerva A; McCarthy LJ
Exp Hematol; 1990 Aug; 18(7):785-8. PubMed ID: 2165911
[TBL] [Abstract][Full Text] [Related]
20. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
